APO Research
Talk to an analyst

APO RESEARCH · REPORT

Telmisartan and Hydrochlorothiazide Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Telmisartan and Hydrochlorothiazide Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchTelmisartan and Hydrochlorothiazide Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Telmisartan and Hydrochlorothiazide Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Telmisartan and Hydrochlorothiazide Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Telmisartan and Hydrochlorothiazide Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Telmisartan and Hydrochlorothiazide Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Telmisartan and Hydrochlorothiazide Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Telmisartan and Hydrochlorothiazide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Telmisartan and Hydrochlorothiazide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Telmisartan and Hydrochlorothiazide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Telmisartan and Hydrochlorothiazide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Telmisartan and Hydrochlorothiazide Drug include Alembic Pharmaceutical, Aurobindo, Boehringer Ingelheim, Lupin Pharmaceuticals, Macleods, Torrent Pharmaceuticals, Zydus Pharmaceuticals, Mylan Pharmaceuticals and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Telmisartan and Hydrochlorothiazide Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Telmisartan and Hydrochlorothiazide Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Telmisartan and Hydrochlorothiazide Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Telmisartan and Hydrochlorothiazide Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Telmisartan and Hydrochlorothiazide Drug Segment by Company

Alembic Pharmaceutical

Aurobindo

Boehringer Ingelheim

Lupin Pharmaceuticals

Macleods

Torrent Pharmaceuticals

Zydus Pharmaceuticals

Mylan Pharmaceuticals

Teva

Huahai Pharmaceutical

Telmisartan and Hydrochlorothiazide Drug Segment by Type

80 mg/25 mg Tablets

80 mg/12.5 mg Tablets

40 mg/12.5 mg Tablets

Telmisartan and Hydrochlorothiazide Drug Segment by Application

High Blood Pressure (Hypertension)

Others

Telmisartan and Hydrochlorothiazide Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Telmisartan and Hydrochlorothiazide Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Telmisartan and Hydrochlorothiazide Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Telmisartan and Hydrochlorothiazide Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Telmisartan and Hydrochlorothiazide Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Telmisartan and Hydrochlorothiazide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Telmisartan and Hydrochlorothiazide Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Telmisartan and Hydrochlorothiazide Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Telmisartan and Hydrochlorothiazide Drug Industry Trends Table 2. Telmisartan and Hydrochlorothiazide Drug Industry Drivers Table 3. Telmisartan and Hydrochlorothiazide Drug Industry Opportunities and Challenges Table 4. Telmisartan and Hydrochlorothiazide Drug Industry Restraints Table 5. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Telmisartan and Hydrochlorothiazide Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Manufacturers Table 9. Global Telmisartan and Hydrochlorothiazide Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Telmisartan and Hydrochlorothiazide Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Telmisartan and Hydrochlorothiazide Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Telmisartan and Hydrochlorothiazide Drug Manufacturers, Product Type & Application Table 13. Global Telmisartan and Hydrochlorothiazide Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Telmisartan and Hydrochlorothiazide Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 80 mg/25 mg Tablets Table 17. Major Manufacturers of 80 mg/12.5 mg Tablets Table 18. Major Manufacturers of 40 mg/12.5 mg Tablets Table 19. Global Telmisartan and Hydrochlorothiazide Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Telmisartan and Hydrochlorothiazide Drug Sales by Type (2021-2026) & (W Units) Table 21. Global Telmisartan and Hydrochlorothiazide Drug Sales by Type (2027-2032) & (W Units) Table 22. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Type (2021-2026) Table 23. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Type (2027-2032) Table 24. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Type (2021-2026) & (W Units) Table 26. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Type (2027-2032) & (W Units) Table 27. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Type (2021-2026) Table 28. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of High Blood Pressure (Hypertension) Table 30. Major Manufacturers of Others Table 31. Global Telmisartan and Hydrochlorothiazide Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Telmisartan and Hydrochlorothiazide Drug Sales by Application (2021-2026) & (W Units) Table 33. Global Telmisartan and Hydrochlorothiazide Drug Sales by Application (2027-2032) & (W Units) Table 34. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Application (2021-2026) Table 35. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Application (2027-2032) Table 36. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Application (2021-2026) & (W Units) Table 38. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Application (2027-2032) & (W Units) Table 39. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Application (2021-2026) Table 40. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Application (2027-2032) Table 41. Global Telmisartan and Hydrochlorothiazide Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Telmisartan and Hydrochlorothiazide Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Region (2021-2026) Table 44. Global Telmisartan and Hydrochlorothiazide Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Telmisartan and Hydrochlorothiazide Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2026) & (W Units) Table 48. North America Telmisartan and Hydrochlorothiazide Drug Sales by Country (2027-2032) & (W Units) Table 49. Europe Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2026) & (W Units) Table 51. Europe Telmisartan and Hydrochlorothiazide Drug Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Sales by Country (2027-2032) & (W Units) Table 58. Global Telmisartan and Hydrochlorothiazide Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Region (2021-2026) Table 62. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Region (2027-2032) Table 63. Alembic Pharmaceutical Company Information Table 64. Alembic Pharmaceutical Business Overview Table 65. Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 67. Alembic Pharmaceutical Recent Development Table 68. Aurobindo Company Information Table 69. Aurobindo Business Overview Table 70. Aurobindo Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Aurobindo Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 72. Aurobindo Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Lupin Pharmaceuticals Company Information Table 79. Lupin Pharmaceuticals Business Overview Table 80. Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 82. Lupin Pharmaceuticals Recent Development Table 83. Macleods Company Information Table 84. Macleods Business Overview Table 85. Macleods Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Macleods Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 87. Macleods Recent Development Table 88. Torrent Pharmaceuticals Company Information Table 89. Torrent Pharmaceuticals Business Overview Table 90. Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 92. Torrent Pharmaceuticals Recent Development Table 93. Zydus Pharmaceuticals Company Information Table 94. Zydus Pharmaceuticals Business Overview Table 95. Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 97. Zydus Pharmaceuticals Recent Development Table 98. Mylan Pharmaceuticals Company Information Table 99. Mylan Pharmaceuticals Business Overview Table 100. Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 102. Mylan Pharmaceuticals Recent Development Table 103. Teva Company Information Table 104. Teva Business Overview Table 105. Teva Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 107. Teva Recent Development Table 108. Huahai Pharmaceutical Company Information Table 109. Huahai Pharmaceutical Business Overview Table 110. Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Portfolio Table 112. Huahai Pharmaceutical Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Telmisartan and Hydrochlorothiazide Drug Distributors List Table 116. Telmisartan and Hydrochlorothiazide Drug Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Telmisartan and Hydrochlorothiazide Drug Product Image Figure 2. Global Telmisartan and Hydrochlorothiazide Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Telmisartan and Hydrochlorothiazide Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Telmisartan and Hydrochlorothiazide Drug Sales (2021-2032) & (W Units) Figure 5. Global Telmisartan and Hydrochlorothiazide Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Telmisartan and Hydrochlorothiazide Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 80 mg/25 mg Tablets Image Figure 9. 80 mg/12.5 mg Tablets Image Figure 10. 40 mg/12.5 mg Tablets Image Figure 11. Global Telmisartan and Hydrochlorothiazide Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Type (2021-2032) Figure 14. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Type (2021-2032) Figure 17. High Blood Pressure (Hypertension) Image Figure 18. Others Image Figure 19. Global Telmisartan and Hydrochlorothiazide Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Application (2021-2032) Figure 22. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Country (2021-2032) Figure 39. China Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Telmisartan and Hydrochlorothiazide Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Telmisartan and Hydrochlorothiazide Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Telmisartan and Hydrochlorothiazide Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Telmisartan and Hydrochlorothiazide Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 80 mg/25 mg Tablets
  • 80 mg/12.5 mg Tablets
  • 40 mg/12.5 mg Tablets
Applications
  • High Blood Pressure (Hypertension)
  • Others
Companies covered
  • Alembic Pharmaceutical
  • Aurobindo
  • Boehringer Ingelheim
  • Lupin Pharmaceuticals
  • Macleods
  • Torrent Pharmaceuticals
  • Zydus Pharmaceuticals
  • Mylan Pharmaceuticals
  • Teva
  • Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Telmisartan and Hydrochlorothiazide Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Telmisartan and Hydrochlorothiazide Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Telmisartan and Hydrochlorothiazide Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Telmisartan and Hydrochlorothiazide Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Telmisartan and Hydrochlorothiazide Drug Market Dynamics
  1. 2.1 Telmisartan and Hydrochlorothiazide Drug Industry Trends
  2. 2.2 Telmisartan and Hydrochlorothiazide Drug Industry Drivers
  3. 2.3 Telmisartan and Hydrochlorothiazide Drug Industry Opportunities and Challenges
  4. 2.4 Telmisartan and Hydrochlorothiazide Drug Industry Restraints
3 Telmisartan and Hydrochlorothiazide Drug Market by Manufacturers
  1. 3.1 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Telmisartan and Hydrochlorothiazide Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Telmisartan and Hydrochlorothiazide Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Telmisartan and Hydrochlorothiazide Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Telmisartan and Hydrochlorothiazide Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Telmisartan and Hydrochlorothiazide Drug Manufacturers, Product Type & Application
  7. 3.7 Global Telmisartan and Hydrochlorothiazide Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Telmisartan and Hydrochlorothiazide Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Telmisartan and Hydrochlorothiazide Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Telmisartan and Hydrochlorothiazide Drug Tier 1, Tier 2, and Tier 3
4 Telmisartan and Hydrochlorothiazide Drug Market by Type
  1. 4.1 Telmisartan and Hydrochlorothiazide Drug Type Introduction
  2. 4.1.1 80 mg/25 mg Tablets
  3. 4.1.2 80 mg/12.5 mg Tablets
  4. 4.1.3 40 mg/12.5 mg Tablets
  5. 4.2 Global Telmisartan and Hydrochlorothiazide Drug Sales by Type
  6. 4.2.1 Global Telmisartan and Hydrochlorothiazide Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Telmisartan and Hydrochlorothiazide Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Type
  10. 4.3.1 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Type (2021-2032)
5 Telmisartan and Hydrochlorothiazide Drug Market by Application
  1. 5.1 Telmisartan and Hydrochlorothiazide Drug Application Introduction
  2. 5.1.1 High Blood Pressure (Hypertension)
  3. 5.1.2 Others
  4. 5.2 Global Telmisartan and Hydrochlorothiazide Drug Sales by Application
  5. 5.2.1 Global Telmisartan and Hydrochlorothiazide Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Telmisartan and Hydrochlorothiazide Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Application
  9. 5.3.1 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Application (2021-2032)
6 Global Telmisartan and Hydrochlorothiazide Drug Sales by Region
  1. 6.1 Global Telmisartan and Hydrochlorothiazide Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Telmisartan and Hydrochlorothiazide Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Telmisartan and Hydrochlorothiazide Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Region
  1. 7.1 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Region
  2. 7.1.1 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032)
  8. 7.2.2 North America Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032)
  11. 7.3.2 Europe Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Telmisartan and Hydrochlorothiazide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic Pharmaceutical
  2. 8.1.1 Alembic Pharmaceutical Company Information
  3. 8.1.2 Alembic Pharmaceutical Business Overview
  4. 8.1.3 Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  6. 8.1.5 Alembic Pharmaceutical Recent Developments
  7. 8.2 Aurobindo
  8. 8.2.1 Aurobindo Company Information
  9. 8.2.2 Aurobindo Business Overview
  10. 8.2.3 Aurobindo Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aurobindo Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  12. 8.2.5 Aurobindo Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Lupin Pharmaceuticals
  20. 8.4.1 Lupin Pharmaceuticals Company Information
  21. 8.4.2 Lupin Pharmaceuticals Business Overview
  22. 8.4.3 Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  24. 8.4.5 Lupin Pharmaceuticals Recent Developments
  25. 8.5 Macleods
  26. 8.5.1 Macleods Company Information
  27. 8.5.2 Macleods Business Overview
  28. 8.5.3 Macleods Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Macleods Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  30. 8.5.5 Macleods Recent Developments
  31. 8.6 Torrent Pharmaceuticals
  32. 8.6.1 Torrent Pharmaceuticals Company Information
  33. 8.6.2 Torrent Pharmaceuticals Business Overview
  34. 8.6.3 Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  36. 8.6.5 Torrent Pharmaceuticals Recent Developments
  37. 8.7 Zydus Pharmaceuticals
  38. 8.7.1 Zydus Pharmaceuticals Company Information
  39. 8.7.2 Zydus Pharmaceuticals Business Overview
  40. 8.7.3 Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  42. 8.7.5 Zydus Pharmaceuticals Recent Developments
  43. 8.8 Mylan Pharmaceuticals
  44. 8.8.1 Mylan Pharmaceuticals Company Information
  45. 8.8.2 Mylan Pharmaceuticals Business Overview
  46. 8.8.3 Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  48. 8.8.5 Mylan Pharmaceuticals Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 Huahai Pharmaceutical
  56. 8.10.1 Huahai Pharmaceutical Company Information
  57. 8.10.2 Huahai Pharmaceutical Business Overview
  58. 8.10.3 Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Portfolio
  60. 8.10.5 Huahai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Telmisartan and Hydrochlorothiazide Drug Value Chain Analysis
  2. 9.1.1 Telmisartan and Hydrochlorothiazide Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Telmisartan and Hydrochlorothiazide Drug Production Mode & Process
  6. 9.2 Telmisartan and Hydrochlorothiazide Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Telmisartan and Hydrochlorothiazide Drug Distributors
  9. 9.2.3 Telmisartan and Hydrochlorothiazide Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst